Regeneron Pharmaceuticals, Inc. (REGN)
785.51
+18.88
(+2.46%)
USD |
NASDAQ |
Feb 06, 16:00
784.85
-0.66
(-0.08%)
Pre-Market: 20:00
Regeneron Pharmaceuticals Total Liabilities (Quarterly) : 9.302B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 81.93B |
| Gilead Sciences, Inc. | 37.08B |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.56B |
| Shareholders Equity (Quarterly) | 31.26B |
| Debt to Equity Ratio | 0.0951 |
| Current Ratio | 4.126 |
| Net Debt Paydown Yield | -0.07% |